Amphastar Pharmaceuticals Share Price Today
(NASDAQ: AMPH)

Name: Amphastar Pharmaceuticals Share Price Today (NASDAQ: AMPH) - Amphastar Pharmaceuticals Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Amphastar Pharmaceuticals share price is $31.28 & ₹2,712.79 as on 22 Feb 2025, 2.30 'hrs' IST

$31.28

▲

-0.02

(-0.06%)

Market is closed - opens 8 PM, 24 Feb 2025

View live Amphastar Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Amphastar Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Amphastar Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Amphastar Pharmaceuticals share price movements

Today's Low: $30.96
Today's High: $31.58
$31.28
1.02%
Downside
Day's Volatility :1.96%
Upside
0.95%
52 Weeks Low: $30.34
52 Weeks High: $56.38
$31.28
3.01%
Downside
52 Weeks Volatility :46.19%
Upside
44.52%

Amphastar Pharmaceuticals (AMPH) Returns

Period	Amphastar Pharmaceuticals Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-29.93%	1.6%	0.0%
6 Months	-35.04%	-5.8%	0.0%
1 Year	-43.22%	-1.0%	0.0%
3 Years	8.72%	15.7%	-9.0%

Amphastar Pharmaceuticals (AMPH) Key Statistics

in dollars & INR

Previous Close	$31.3
Open	$31.55
Today's High	$31.58
Today's Low	$30.96
Market Capitalization	$1.5B
Today's Volume	$498.8K
52 Week High	$56.38
52 Week Low	$30.34
Revenue TTM	$723.5M
EBITDA	$266.6M
Earnings Per Share (EPS)	$3.01
PE Ratio	10.4
Profit Margin	21.8%
Quarterly Earnings Growth YOY	-0.14%
Return On Equity TTM	23.85%

How to invest in Amphastar Pharmaceuticals Stock (AMPH) from India?

It is very easy for Indian residents to invest directly in Amphastar Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Amphastar Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Amphastar Pharmaceuticals or AMPH on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Amphastar Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Amphastar Pharmaceuticals shares which would translate to 0.028 fractional shares of Amphastar Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Amphastar Pharmaceuticals, in just a few clicks!

Returns in Amphastar Pharmaceuticals (AMPH) for Indian investors in Rupees

The Amphastar Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Amphastar Pharmaceuticals investment value today

Current value as on today

₹61,429

Returns

₹38,571

(-38.57%)

Returns from Amphastar Pharmaceuticals Stock

₹43,220 (-43.22%)

Dollar Returns

₹4,649 (+4.65%)

Indian investors sentiment towards Amphastar Pharmaceuticals (AMPH)

-21%

Period: Jan 24, 2025 to Feb 23, 2025. Change in 30 Days versus previous period

Search interest for Amphastar Pharmaceuticals Stock from India on INDmoney has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Amphastar Pharmaceuticals

BlackRock Inc
12.55%
Vanguard Group Inc
5.65%
Federated Hermes Inc
4.05%
TD Asset Management Inc
3.83%
Neuberger Berman Group LLC
3.36%
State Street Corp
3.18%

Analyst Recommendation on Amphastar Pharmaceuticals

Buy

75%Buy

25%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Amphastar Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Amphastar Pharmaceuticals Stock (AMPH)

What analysts predicted

Upside of 41.94%

Target:

$44.40

Current:

$31.28

Insights on Amphastar Pharmaceuticals Stock (Ticker Symbol: AMPH)

Price Movement
In the last 1 month, AMPH stock has moved down by -14.0%
Increasing Revenue
Revenue is up for the last 3 quarters, 171.83M → 188.81M (in $), with an average increase of 4.6% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, 37.94M → 40.42M (in $), with an average increase of 6.1% per quarter
AMPH vs ITCI (1 yr)
In the last 1 year, Intra-cellular Therapies, Inc. has given 83.3% return, outperforming this stock by 124.7%
AMPH vs ITCI (3 yr)
In the last 3 years, Intra-cellular Therapies, Inc. has given 142.4% return, outperforming this stock by 128.5%
Price to Sales
ForAMPH every $1 of sales, investors are willing to pay $2.1, whereas for Intra-cellular Therapies, Inc., the investors are paying $21.1 for every $1 of sales.

AMPH Amphastar Pharmaceuticals Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$294.7M	↑ 22.69%
Net Income	$-5.7M	↓ 227.28%
Net Profit Margin	-1.95%	↓ 3.83%

	FY19	Y/Y Change
Revenue	$322.4M	↑ 9.4%
Net Income	$48.9M	↓ 952.89%
Net Profit Margin	15.18%	↑ 17.13%

	FY20	Y/Y Change
Revenue	$349.8M	↑ 8.53%
Net Income	$1.1M	↓ 97.76%
Net Profit Margin	0.31%	↓ 14.87%

	FY21	Y/Y Change
Revenue	$437.8M	↑ 25.13%
Net Income	$62.1M	↑ 5562.35%
Net Profit Margin	14.19%	↑ 13.88%

	FY22	Y/Y Change
Revenue	$499.0M	↑ 13.98%
Net Income	$91.4M	↑ 47.12%
Net Profit Margin	18.31%	↑ 4.12%

	FY23	Y/Y Change
Revenue	$644.4M	↑ 29.14%
Net Income	$137.5M	↑ 50.51%
Net Profit Margin	21.34%	↑ 3.03%

	Q2 FY23	Q/Q Change
Revenue	$145.7M	↑ 4.06%
Net Income	$26.1M	↑ 0.35%
Net Profit Margin	17.93%	↓ 0.66%

	Q3 FY23	Q/Q Change
Revenue	$180.6M	↑ 23.91%
Net Income	$49.2M	↑ 88.42%
Net Profit Margin	27.26%	↑ 9.33%

	Q4 FY23	Q/Q Change
Revenue	$178.1M	↓ 1.36%
Net Income	$36.2M	↓ 26.52%
Net Profit Margin	20.31%	↓ 6.95%

	Q1 FY24	Q/Q Change
Revenue	$171.8M	↓ 3.52%
Net Income	$43.2M	↑ 19.38%
Net Profit Margin	25.13%	↑ 4.82%

	Q2 FY24	Q/Q Change
Revenue	$182.4M	↑ 6.14%
Net Income	$37.9M	↓ 12.11%
Net Profit Margin	20.81%	↓ 4.32%

	Q3 FY24	Q/Q Change
Revenue	$188.8M	↑ 3.52%
Net Income	$40.4M	↑ 6.54%
Net Profit Margin	21.41%	↑ 0.6%

	FY18	Y/Y Change
Profit	$107.0M	↑ 17.83%

	FY19	Y/Y Change
Profit	$131.9M	↑ 23.31%

	FY20	Y/Y Change
Profit	$143.3M	↑ 8.65%

	FY21	Y/Y Change
Profit	$199.7M	↑ 39.35%

	FY22	Y/Y Change
Profit	$248.9M	↑ 24.59%

	FY23	Y/Y Change
Profit	$351.1M	↑ 41.09%

	Q2 FY23	Q/Q Change
Profit	$72.7M	↓ 1.49%

	Q3 FY23	Q/Q Change
Profit	$108.4M	↑ 49.03%

	Q4 FY23	Q/Q Change
Profit	$93.6M	↓ 13.69%

	Q1 FY24	Q/Q Change
Profit	$87.3M	↓ 6.71%

	Q2 FY24	Q/Q Change
Profit	$92.0M	↑ 5.45%

	Q3 FY24	Q/Q Change
Profit	$101.9M	↑ 10.75%

	FY18	Y/Y Change
Operating Cash Flow	$38.2M	↓ 2.6%
Investing Cash Flow	$-42.2M	↑ 8.84%
Financing Cash Flow	$25.0M	↓ 424.02%

	FY19	Y/Y Change
Operating Cash Flow	$41.8M	↑ 9.35%
Investing Cash Flow	$-50.5M	↑ 19.78%
Financing Cash Flow	$-3.8M	↓ 115.13%

	FY20	Y/Y Change
Operating Cash Flow	$57.3M	↑ 37.12%
Investing Cash Flow	$-36.4M	↓ 27.93%
Financing Cash Flow	$-2.2M	↓ 40.63%

	FY21	Y/Y Change
Operating Cash Flow	$98.0M	↑ 71.12%
Investing Cash Flow	$-28.7M	↓ 21.26%
Financing Cash Flow	$-37.0M	↑ 1548.17%

	FY22	Y/Y Change
Operating Cash Flow	$89.2M	↓ 8.99%
Investing Cash Flow	$-32.8M	↑ 14.32%
Financing Cash Flow	$-26.4M	↓ 28.58%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$54.9M	↑ 36.01%
Investing Cash Flow	$-508.6M	↑ 7930.66%
Financing Cash Flow	$428.1M	↓ 3259.96%

Amphastar Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Amphastar Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Amphastar Pharmaceuticals (AMPH) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Amphastar Pharmaceuticals Inc	-14.3%	-35.04%	-43.22%	8.72%	81.02%
Intra-cellular Therapies, Inc.	1.09%	72.64%	79.71%	132.63%	478.24%
Haleon Plc Spon Ads	7.35%	2.13%	21.89%	36.03%	36.03%
Zoetis Inc.	-4.83%	-11.62%	-18.56%	-17.59%	17.86%
Neurocrine Biosciences Inc.	-18.85%	-20.74%	-10.98%	35.82%	28.46%
Viatris Inc.	0.45%	-4.26%	-16.23%	-22.63%	-31.15%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Amphastar Pharmaceuticals Inc	10.4	10.4	2.77	3.87	0.24	0.09	NA	15.04
Intra-cellular Therapies, Inc.	NA	NA	0.0	-0.71	-0.1	-0.07	NA	10.8
Haleon Plc Spon Ads	30.55	30.55	1.73	0.36	0.07	0.04	0.02	1.82
Zoetis Inc.	29.39	29.39	2.78	6.14	0.51	0.15	0.01	10.64
Neurocrine Biosciences Inc.	36.68	36.68	0.27	6.46	0.14	0.1	NA	26.05
Viatris Inc.	224.4	NA	0.07	2.68	-0.04	0.02	0.04	16.58

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Amphastar Pharmaceuticals Inc	Buy	$1.5B	81.02%	10.4	21.8%
Intra-cellular Therapies, Inc.	Buy	$13.7B	478.24%	NA	-14.07%
Haleon Plc Spon Ads	Buy	$45.6B	36.03%	30.55	10.75%
Zoetis Inc.	Buy	$71.9B	17.86%	29.39	26.86%
Neurocrine Biosciences Inc.	Buy	$12.0B	28.46%	36.68	14.49%
Viatris Inc.	Hold	$13.2B	-31.15%	224.4	-5.87%

About Amphastar Pharmaceuticals

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, to prevent and treat deep vein thrombosis; REXTOVY and Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company provides Amphadase, an injection to absorb and disperse other injected drugs; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products; morphine injection for use with patient-controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges; Vasopressin to increase blood pressure; and Regadenoson, a stress agent for radionuclide myocardial perfusion imaging. Further, the company distributes recombinant human insulin APIs and porcine insulin API. Additionally, it develops generic product candidates, such as injectable, inhalation, and analytical technologies; biosimial product candidates; and intranasal epinephrine for the treatment of allergic reactions. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Organization	Amphastar Pharmaceuticals
Employees	1761
CEO	Dr. Yongfeng Zhang Ph.D.
Industry	Health Technology

Management People of Amphastar Pharmaceuticals

Name	Title
Dr. Ziping Luo Ph.D.	Chairman of the Board, Chief Scientist & COO
Dr. Yongfeng Zhang Ph.D.	Co-Founder, President, CEO, Chief Scientific Officer & Director
Mr. William J. Peters M.B.A.	CFO, Executive VP of Finance, Treasurer & Director
Mr. Jacob Liawatidewi M.B.A.	Executive VP of Sales, Marketing & Corporate Administration Center, Corporate Secretary and Director
Mr. Rong Zhou M.S.	Senior EVP of Production & EVP of Scientific Affairs
Mr. Dan Dischner M.B.A.	Senior Vice President of Human Resources & Corporate Communication
Tony Marrs M.B.A., M.P.H., M.S.	Executive VP of Regulatory Affairs & Clinical Operations

Important FAQs about investing in AMPH Stock from India :

What is Amphastar Pharmaceuticals share price today?

Amphastar Pharmaceuticals share price today stands at $31.28, Open: $31.55 ; Previous Close: $31.30 ; High: $31.58 ; Low: $30.96 ; 52 Week High: $56.38 ; 52 Week Low: $30.34.

The stock opens at $31.55, after a previous close of $31.30. The stock reached a daily high of $31.58 and a low of $30.96, with a 52-week high of $56.38 and a 52-week low of $30.34.

Can Indians buy Amphastar Pharmaceuticals shares?

Yes, Indians can invest in the Amphastar Pharmaceuticals (AMPH) from India.

With INDmoney, you can buy Amphastar Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Amphastar Pharmaceuticals at zero transaction cost.

How can I buy Amphastar Pharmaceuticals shares from India?

It is very easy to buy Amphastar Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Amphastar Pharmaceuticals (AMPH) be purchased?

Yes, you can buy fractional shares of Amphastar Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Amphastar Pharmaceuticals stocks?

To start investing in Amphastar Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.